We cultured enterococci from urinary tract infections in Iranian hospitals. Seven different Enterococcus species (E. raffinosus, E. durans, E. hirae, E. avium, E. mundtii, E. faecium and E. faecalis) were found. Seven strains were vancomycin resistant, leading to an overall vancomycin resistance rate of 3.9%. The enterococcal infection rate was high and vancomycin-resistant enterococci incidence low. We report the first vanA-positive E. mundtii urinary tract infections.
Enterococci are members of the gastrointestinal flora and emerged in the 1970s as leading causes of multidrug-resistant hospital acquired infections [1] . Enterococcal colonization may result in asymptomatic bacteriuria but also in overt urinary tract infection (UTI) [2] . Vancomycin-resistant enterococci (VRE), the most important class of drug-resistant enterococci, mainly belong to the species Enterococcus faecium and contain vanA and/or vanB genes [3] . There are four additional vancomycin resistance genes: vanC, vanD, vanE and vanG [4, 5] . Detection of VRE is possible with culture or PCR [6] . We investigated UTI-related VRE and their vanA and vanB content from samples of East Iranian origin.
We obtained 177 isolates from 358 urine specimens of patients with UTI from two hospitals (Amir Al-Momenin and Imam Khomeini) in Zabol, Iran (2013 Iran ( -2014 . Diagnostics included Gram staining, catalase production, pyrrolidonyl arylamidase detection and growth on bile-esculin/6.5% NaCl media. Vancomycin susceptibility testing included screening on brain-heart infusion (BHI) agar (Difco, USA) containing 6 μg/ mL vancomycin (Sigma, Germany). Teicoplanin susceptibility testing was performed using 30 μg teicoplanin disks on MuellerHinton agar (Difco; Mast, UK). Minimum inhibitory concentrations (MICs) were determined by agar dilution on BHI agar [7] . The MIC breakpoint for both vancomycin and teicoplanin resistance was 32 μg/mL. Susceptibility to vancomycin (MIC 4 μg/mL) and to teicoplanin (MIC 8 μg/mL) was according to the Clinical and Laboratory Standards Institute.
DNA was extracted according to Perez-Hernandez et al. [8] and used for vanA and vanB PCR. All enterococci were PCR assayed for vanA and vanB genes using previously described primers and protocols [9] . Resistant Enterococcus spp. strains E. faecalis E206 (vanA positive) and E. faecium E2781 (vanB positive) were used as positive controls; Enterococcus faecalis ATCC 29212 was used as negative control.
We identified seven different species of Enterococcus: E. raffinosus 3.3% (n = 6), E. durans 2.8% (n = 5), E. hirae 3.9% (n = 7), E. avium 4.5% (n = 8), E. mundtii 10% (n = 18), E. faecium 27% (n = 48), and E. faecalis 48% (n = 85) (n = resistant to vancomycin: E. raffinosus (n = 1), E. faecalis (n = 2) and E. mundtii (n = 1) (see Fig. 1 ). Imam Khomeini Hospital showed an even lower resistance rate of 3.6% (n = 3), including two E. raffinosus and one E. faecium strains. The overall vancomycin resistance rate in the two hospitals was 3.9% ( Table 2 ).
All strains resistant to vancomycin showed an MIC of >512 μg/mL, while MICs obtained for teicoplanin resistant strains varied. E. faecium showed the highest teicoplanin MIC (98 μg/mL). E. faecalis (69 μg/mL), E. mundtii (60 μg/mL) and E. raffinosus (18 μg/mL) showed lower MICs.
Hospital-based VRE endemicity differs between countries, within a country and between different cities or hospitals. Here we show that the enterococcal UTI rate in two Iranian medical centers was relatively high. The VRE incidence, however, was not excessive. We show further evidence for the existence of infectious vanA-positive E. mundtii in humans beyond the single case previously reported from India [10] . 
